Immunosuppressants and risk of Parkinson disease

We performed a population‐based case–control study of United States Medicare beneficiaries age 60–90 in 2009 with prescription data (48,295 incident Parkinson disease cases and 52,324 controls) to examine the risk of Parkinson disease in relation to use of immunosuppressants. Inosine monophosphate d...

Descripción completa

Detalles Bibliográficos
Autores principales: Racette, Brad A., Gross, Anat, Vouri, Scott Martin, Camacho‐Soto, Alejandra, Willis, Allison W., Searles Nielsen, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043771/
https://www.ncbi.nlm.nih.gov/pubmed/30009205
http://dx.doi.org/10.1002/acn3.580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043771/
https://www.ncbi.nlm.nih.gov/pubmed/30009205
http://dx.doi.org/10.1002/acn3.580

Ejemplares similares